Republicans eager to buck vaccine mandates have embraced the argument that immunity from earlier infections should be enough to earn an exemption. Scientists says vaccines offer a more consistent level of protection for people who have had COVID-19.
The Republican-led New Hampshire Legislature plans to take up a similar measure when it meets in January. Lawmakers in Idaho and Wyoming, both statehouses under GOP-control, recently debated similar measures but did not pass them. In Utah, a newly signed law creating exemptions from Biden’s vaccine mandates for private employers allows people to duck the requirement if they have already had COVID.
Some politicians use the science behind natural immunity to advance narratives suggesting vaccines aren’t the best way to end the pandemic. “The shot is not by any means the only or proven way out of the pandemic. I’m not willing to give blind faith to the pharmaceutical narrative,” said Idaho Republican Rep. Greg Ferch., a Kansas Republican and physician, along with 14 other GOP doctors, dentists and pharmacists in Congress, sent a letter in late September to the Centers for Disease Control and Prevention, urging the agency, when setting vaccination policies, to consider natural immunity.
The White House has recently unveiled a host of vaccine mandates, sparking a flurry of lawsuits from GOP states, setting the stage for pitched legal battles. Among the rules are vaccine requirements for federal contractors, businesses with more than 100 employees and health care workers.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Protesters petition Robin Swann over care home Covid rulesResidents' relatives said pandemic restrictions are having a detrimental affect on their loved ones.
Read more »
U.S. looking to broaden access to COVID-19 antiviral pills - WSJThe administration is reviewing whether Paxlovid, the antiviral from Pfizer Inc, can be available on the commercial market in retail pharmacies if it gets regulatory clearance, the Journal reported. Molnupiravir, an oral pill from Merck & Co Inc and Ridgeback Biotherapeutics LP that is also under regulatory review, may be included in the government's plan to make it commercially available, the journal reported, citing the person. The United States has agreed to buy 10 million courses of Pfizer's drug and has so far secured 3.1 million courses of Merck's pill.
Read more »
Everything you need to know about getting a COVID-19 boosterMixing and matching is approved, and all adults are currently eligible for booster shots.
Read more »
All U.S. Adults Can Now Get a COVID-19 Booster Shotthe FDA approved booster shots for everyone 18 and older who received their second dose of the Pfizer or Moderna vaccine at least six months ago.
Read more »
What will the covid-19 pandemic look like in 2022?Immunity and treatment options will increase—but poor countries will lose out
Read more »
The FDA Just Authorized COVID-19 Vaccine Booster Shots for All AdultsHere's what you should know.
Read more »